Cancer Incidence and Mortality for New York State Excl New York City, 2016-2020

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 73,383.6 501.9 500.2-503.6 37,437.6 546.8 544.2-549.3 35,946.0 471.9 469.6-474.2 21,818.2 143.4 142.6-144.3 11,060.2 166.1 164.6-167.5 10,758.0 127.7 126.5-128.8
Oral cavity and pharynx 1,840.2 12.4 12.1-12.6 1,280.2 18.3 17.8-18.7 560.0 7.1 6.9-7.4 343.0 2.2 2.1-2.3 237.6 3.4 3.2-3.6 105.4 1.2 1.1-1.4
Esophagus 763.2 5.0 4.8-5.2 590.6 8.5 8.2-8.8 172.6 2.1 1.9-2.2 615.8 4.0 3.9-4.1 487.4 7.0 6.7-7.3 128.4 1.5 1.4-1.6
Stomach 1,047.6 7.2 7.0-7.4 641.0 9.5 9.2-9.9 406.6 5.2 5.0-5.5 370.8 2.5 2.4-2.6 218.4 3.3 3.1-3.5 152.4 1.9 1.7-2.0
Colorectal 5,366.4 37.2 36.8-37.7 2,778.8 42.1 41.4-42.9 2,587.6 33.1 32.5-33.7 1,768.4 11.7 11.5-12.0 900.6 13.7 13.3-14.1 867.8 10.1 9.8-10.5
Colon excluding rectum 3,801.2 26.2 25.8-26.6 1,862.8 28.4 27.8-29.0 1,938.4 24.4 23.9-24.9 1,379.8 9.1 8.9-9.4 679.6 10.4 10.0-10.7 700.2 8.1 7.8-8.4
Rectum & rectosigmoid 1,565.2 11.0 10.8-11.3 916.0 13.8 13.4-14.2 649.2 8.6 8.3-9.0 388.6 2.6 2.5-2.7 221.0 3.3 3.1-3.5 167.6 2.0 1.9-2.2
Liver / intrahepatic bile duct 1,171.0 7.5 7.3-7.7 828.4 11.5 11.1-11.8 342.6 4.2 4.0-4.4 785.6 5.1 4.9-5.2 527.2 7.5 7.2-7.8 258.4 3.1 2.9-3.3
Pancreas 2,290.6 15.1 14.8-15.4 1,180.0 17.3 16.8-17.8 1,110.6 13.3 12.9-13.7 1,742.6 11.4 11.1-11.6 882.6 13.0 12.6-13.4 860.0 10.0 9.7-10.3
Larynx 462.4 3.0 2.9-3.1 364.6 5.1 4.9-5.4 97.8 1.2 1.1-1.4 125.8 0.8 0.7-0.9 98.8 1.4 1.3-1.5 27.0 0.3 0.3-0.4
Lung and bronchus 9,633.2 62.7 62.2-63.3 4,579.2 66.3 65.4-67.2 5,054.0 60.5 59.7-61.2 5,250.4 34.1 33.7-34.5 2,649.4 39.0 38.3-39.7 2,601.0 30.5 30.0-31.1
Melanoma of the skin 3,302.4 23.3 22.9-23.6 1,922.4 29.0 28.4-29.6 1,380.0 19.2 18.7-19.7 303.4 2.0 1.9-2.1 193.8 3.0 2.8-3.2 109.6 1.3 1.2-1.4
Female breast             10,258.0 139.3 138.0-140.5             1,498.4 18.5 18.0-18.9
Cervix uteri             393.2 6.6 6.3-6.9             122.4 1.7 1.6-1.9
Corpus uterus and NOS             2,513.8 31.6 31.0-32.1             456.0 5.4 5.2-5.6
Ovary             841.4 11.3 10.9-11.6             534.4 6.4 6.2-6.7
Prostate       9,885.0 133.4 132.2-134.6             1,037.8 16.2 15.8-16.7      
Testis       353.8 6.9 6.6-7.3             15.0 0.3 0.2-0.3      
Urinary bladder (incl. in situ) 3,819.0 25.1 24.7-25.5 2,868.6 42.8 42.1-43.5 950.4 11.2 10.9-11.6 663.6 4.3 4.1-4.4 473.6 7.4 7.1-7.7 190.0 2.1 2.0-2.2
Kidney and renal pelvis 2,655.0 18.4 18.1-18.7 1,731.2 25.6 25.0-26.1 923.8 12.2 11.8-12.5 442.4 2.9 2.8-3.0 281.0 4.2 3.9-4.4 161.4 1.9 1.8-2.0
Brain and other central nervous system 892.6 6.9 6.7-7.1 500.4 8.1 7.7-8.4 392.2 5.8 5.5-6.1 610.0 4.3 4.1-4.4 349.6 5.3 5.0-5.5 260.4 3.4 3.2-3.6
Thyroid 2,087.2 17.5 17.2-17.9 594.0 9.8 9.4-10.1 1,493.2 25.3 24.7-25.9 77.0 0.5 0.5-0.6 34.4 0.5 0.5-0.6 42.6 0.5 0.4-0.6
Hodgkin lymphoma 368.6 3.2 3.0-3.3 199.2 3.5 3.2-3.7 169.4 2.9 2.7-3.1 39.6 0.3 0.2-0.3 24.6 0.4 0.3-0.5 15.0 0.2 0.2-0.2
Non-Hodgkin lymphomas 3,160.0 21.9 21.5-22.3 1,710.6 26.0 25.4-26.6 1,449.4 18.6 18.2-19.1 765.8 5.1 4.9-5.2 423.8 6.5 6.3-6.8 342.0 4.0 3.8-4.2
Myeloma 1,138.2 7.6 7.4-7.8 643.2 9.5 9.1-9.8 495.0 6.1 5.9-6.4 410.4 2.7 2.6-2.8 216.2 3.3 3.1-3.5 194.2 2.2 2.1-2.4
Leukemias 2,453.2 17.2 16.9-17.5 1,454.6 22.3 21.8-22.9 998.6 13.0 12.6-13.4 884.2 5.9 5.8-6.1 514.0 8.1 7.8-8.4 370.2 4.3 4.1-4.6

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.